A detailed history of Franklin Resources Inc transactions in Incyte Corp stock. As of the latest transaction made, Franklin Resources Inc holds 201,718 shares of INCY stock, worth $13.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
201,718
Previous 201,718 -0.0%
Holding current value
$13.8 Million
Previous $13.3 Million -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$57.33 - $68.61 $2.88 Million - $3.44 Million
-50,188 Reduced 19.92%
201,718 $13.3 Million
Q2 2024

Aug 14, 2024

SELL
$51.18 - $63.75 $345,157 - $429,930
-6,744 Reduced 2.61%
251,906 $15.3 Million
Q1 2024

May 13, 2024

BUY
$56.55 - $66.59 $11.6 Million - $13.6 Million
204,893 Added 381.15%
258,650 $14.7 Million
Q4 2023

Feb 09, 2024

BUY
$52.16 - $64.19 $618,148 - $760,715
11,851 Added 28.28%
53,757 $3.38 Million
Q3 2023

Nov 13, 2023

BUY
$57.77 - $65.93 $378,682 - $432,171
6,555 Added 18.54%
41,906 $2.42 Million
Q2 2023

Aug 11, 2023

SELL
$60.95 - $75.51 $10.7 Million - $13.3 Million
-176,371 Reduced 83.3%
35,351 $2.2 Million
Q1 2023

May 12, 2023

BUY
$70.23 - $86.01 $294,544 - $360,725
4,194 Added 2.02%
211,722 $15.3 Million
Q4 2022

Feb 10, 2023

BUY
$67.18 - $84.11 $12.6 Million - $15.7 Million
186,978 Added 909.87%
207,528 $16.7 Million
Q3 2022

Nov 14, 2022

BUY
$66.18 - $82.86 $120,513 - $150,888
1,821 Added 9.72%
20,550 $1.37 Million
Q2 2022

Aug 11, 2022

SELL
$66.18 - $83.18 $1.11 Million - $1.39 Million
-16,726 Reduced 47.18%
18,729 $1.42 Million
Q1 2022

May 13, 2022

SELL
$66.02 - $79.71 $41,526 - $50,137
-629 Reduced 1.74%
35,455 $2.82 Million
Q4 2021

Feb 11, 2022

BUY
$63.34 - $74.11 $31,543 - $36,906
498 Added 1.4%
36,084 $2.64 Million
Q3 2021

Nov 12, 2021

BUY
$68.67 - $84.02 $2.02 Million - $2.47 Million
29,388 Added 474.15%
35,586 $2.45 Million
Q2 2021

Aug 13, 2021

BUY
$79.87 - $87.53 $103,431 - $113,351
1,295 Added 26.41%
6,198 $522,000
Q1 2021

May 13, 2021

SELL
$76.02 - $100.5 $13,227 - $17,487
-174 Reduced 3.43%
4,903 $399,000
Q4 2020

Feb 10, 2021

BUY
$80.74 - $97.7 $20,669 - $25,011
256 Added 5.31%
5,077 $442,000
Q3 2020

Nov 12, 2020

BUY
$85.07 - $109.69 $410,122 - $528,815
4,821 New
4,821 $433,000
Q3 2019

Nov 14, 2019

SELL
$72.82 - $86.52 $15.7 Million - $18.6 Million
-215,134 Closed
0 $0
Q2 2019

Aug 14, 2019

SELL
$73.52 - $88.7 $1.5 Million - $1.8 Million
-20,347 Reduced 8.64%
215,134 $18.3 Million
Q1 2019

May 14, 2019

BUY
$63.56 - $88.17 $113,645 - $157,647
1,788 Added 0.77%
235,481 $20.3 Million
Q4 2018

Feb 12, 2019

SELL
$58.5 - $69.94 $40,950 - $48,958
-700 Reduced 0.3%
233,693 $14.9 Million
Q3 2018

Nov 13, 2018

BUY
$61.75 - $74.23 $728,650 - $875,914
11,800 Added 5.3%
234,393 $16.2 Million
Q2 2018

Aug 14, 2018

SELL
$60.85 - $83.98 $79.1 Million - $109 Million
-1,299,530 Reduced 85.38%
222,593 $14.9 Million
Q1 2018

May 10, 2018

SELL
$83.06 - $100.98 $91.5 Million - $111 Million
-1,101,522 Reduced 41.98%
1,522,123 $127 Million
Q4 2017

Feb 14, 2018

SELL
$93.56 - $116.6 $33.8 Million - $42.1 Million
-360,883 Reduced 12.09%
2,623,645 $248 Million
Q3 2017

Nov 13, 2017

BUY
$109.15 - $138.27 $326 Million - $413 Million
2,984,528
2,984,528 $348 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $15.2B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Franklin Resources Inc Portfolio

Follow Franklin Resources Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.